Literature DB >> 9589240

Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study.

C Couillard1, B Lamarche, P Mauriège, B Cantin, G R Dagenais, S Moorjani, P J Lupien, J P Després.   

Abstract

OBJECTIVE: To investigate the possibility that leptin levels may be predictive of the risk of ischemic heart disease (IHD) through the relationship of leptin to body fat. RESEARCH DESIGN AND METHODS: The Quebec Cardiovascular Study cohort consisted of 2,103 French-Canadian men without IHD in 1985 who were followed until 1990, by which time 114 had experienced an IHD event. These 114 men were then individually matched for age, BMI, cigarette smoking, and alcohol intake with 114 subjects who were free of IHD at follow-up. After exclusion of diabetic patients and those in whom leptin levels could not be measured, we were able to compare the initial metabolic profiles of 86 men in the IHD group and of 95 control subjects.
RESULTS: Plasma leptin concentrations were positively correlated with BMI (r = 0.67, P < 0.0001) and with fasting insulin concentrations (r = 0.46, P < 0.0001) in the overall sample. These significant associations were also observed when men with IHD and the control subjects were examined separately (control subjects: r = 0.68 for BMI and r = 0.45 for insulin; IHD subjects: r = 0.65 for BMI and r = 0.50 for insulin). With the exception of plasma triglyceride (r = 0.25, P < 0.001), no significant association was found between leptin and plasma lipoprotein and lipid concentrations. Furthermore, plasma insulin remained significantly associated with leptin levels even after adjustment for BMI (r = 0.22, P < 0.005). There was no difference in baseline leptin levels among men who developed IHD versus men who remained IHD-free during the 5-year follow-up (5.56 +/- 3.12 vs. 5.36 +/- 2.90 ng/ml, respectively). Thus, although significantly correlated with the BMI and fasting insulin levels, plasma leptin concentration was not a significant predictor of the 5-year incidence of IHD. This lack of a relationship to IHD was noted when leptin levels were analyzed as tertiles and when leptin concentration was analyzed as a continuous variable.
CONCLUSIONS: These prospective results suggest that leptinemia, despite being a strong correlate of obesity, does not appear to be an independent risk factor for the development of IHD in men.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9589240     DOI: 10.2337/diacare.21.5.782

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  22 in total

1.  Modulation of leptin levels by oxidized linoleic acid: a connection to atherosclerosis?

Authors:  Meera Penumetcha; Nadya Merchant; Sampath Parthasarathy
Journal:  J Med Food       Date:  2010-12-27       Impact factor: 2.786

Review 2.  Leptin and cardiovascular disease: response to therapeutic interventions.

Authors:  Kwang Kon Koh; Sang Min Park; Michael J Quon
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

3.  The change of serum leptin and its relationship with platelet membrane glycoprotein Ib in patients with coronary heart disease.

Authors:  Dasheng Xia; Yanqiu Song; Chao Li; Feng Zhang; Minxin Wei
Journal:  Front Med China       Date:  2007-10

4.  Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study.

Authors:  A M Brennan; T Y Li; I Kelesidis; A Gavrila; F B Hu; C S Mantzoros
Journal:  Diabetologia       Date:  2007-03-20       Impact factor: 10.122

5.  Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study.

Authors:  Ivy A Ku; Ramin Farzaneh-Far; Eric Vittinghoff; Mary H Zhang; Beeya Na; Mary A Whooley
Journal:  Atherosclerosis       Date:  2010-12-02       Impact factor: 5.162

Review 6.  Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.

Authors:  José J Fuster; Noriyuki Ouchi; Noyan Gokce; Kenneth Walsh
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

7.  Are common leptin promoter polymorphisms associated with restenosis after coronary stenting?

Authors:  Julie Anna Bienertová-Vasků; Ota Hlinomaz; Anna Vasků
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

8.  Higher plasma leptin levels are associated with reduced left ventricular mass and left ventricular diastolic stiffness in black women: insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study.

Authors:  Daisuke Kamimura; Takeki Suzuki; Wanmei Wang; Matthew deShazo; John E Hall; Michael D Winniford; Iftikhar J Kullo; Thomas H Mosley; Kenneth R Butler; Michael E Hall
Journal:  Hypertens Res       Date:  2018-06-15       Impact factor: 3.872

Review 9.  Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.

Authors:  Seth S Martin; Atif Qasim; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2008-10-07       Impact factor: 24.094

Review 10.  Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease.

Authors:  Sanjeev B Patel; Garry P Reams; Robert M Spear; Ronald H Freeman; Daniel Villarreal
Journal:  Curr Hypertens Rep       Date:  2008-04       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.